ABT
$113.86
Revenue | $10377Mn |
Net Profits | $1302Mn |
Net Profit Margins | 12.55% |
PE Ratio | 35.68 |
Abbott Laboratories’s revenue jumped 4% since last year same period to $10377Mn in the Q2 2024. On a quarterly growth basis, Abbott Laboratories has generated 4.14% jump in its revenue since last 3-months.
Abbott Laboratories’s net profit fell -5.31% since last year same period to $1302Mn in the Q2 2024. On a quarterly growth basis, Abbott Laboratories has generated 6.29% jump in its net profits since last 3-months.
Abbott Laboratories’s net profit margin fell -8.95% since last year same period to 12.55% in the Q2 2024. On a quarterly growth basis, Abbott Laboratories has generated 2.06% jump in its net profit margins since last 3-months.
Abbott Laboratories’s price-to-earnings ratio after this Q2 2024 earnings stands at 35.68.
EPS Estimate Current Quarter | 1.2 |
EPS Estimate Current Year | 1.2 |
Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.2 - a 9.09% jump from last quarter’s estimates.
Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.2.
Earning Per Share (EPS) | 1.14 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.14 |
Dividend Per Share (DPS) | 0.55 |
Abbott Laboratories’s earning per share (EPS) jumped 5.56% since last year same period to 1.14 in the Q2 2024. This indicates that the Abbott Laboratories has generated 5.56% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Abbott Laboratories’s return on assets (ROA) stands at 0.06.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Abbott Laboratories’s return on equity (ROE) stands at 0.14.
Abbott Laboratories declared 0.55 dividend per share during the earnings announcement for Q2 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-02 | 0.95 | 0.98 | 3.16% |
2024-07-31 | 1.1 | 1.14 | 3.64% |